Novo Nordisk stock tumbled over the latest results for its experimental weight loss pill
Ozempic maker Novo Nordisk (NVO) announced mixed results today for a phase 2 trial of an experimental weight loss pill that ...
NJBIZ18h
Novo Nordisk expects Ozempic in next round of Medicare price talks
In August 2023, the U.S. Department of Health and Human Services announced the first 10 drugs covered under Medicare Part D ...
European Drug Agency Supports Novo Nordisk's Blockbuster Weight-Loss Drug Wegovy For Obesity-Related Heart Failure
Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for an update of Novo Nordisk A/S’ (NYSE ...
NVO Stock Loses Around $29B in 3 Months: Buy the Dip or Steer Clear?
Despite the current downward trend of Novo Nordisk, it is an excellent stock to buy for long-term gains, driven by the ...
China Cracks Down on Illegal Copies of Novo’s Obesity Drug
China has started cracking down on unlicensed production and sale of medicines similar to Novo Nordisk A/S’s blockbuster ...
The price war in weight-loss drugs is here
Novo Nordisk and Eli Lilly are offering discounts to encourage more insurance coverage of the medicines, which carry price ...
U.S. weight-loss medicine makers cut prices for insurance inclusion: WSJ
Eli Lilly and Novo Nordisk the pharmaceutical heavyweights selling popular weight-loss injections are each dangling discounts to gain an edge and to ...
Research That Led to Obesity Drugs Wins Major Medical Prize
Three scientists were recognized by the Lasker Awards for their work on the GLP-1 hormone. Others were honored for work to ...
Are We Thinking About Obesity All Wrong?
It’s a brain disease,” a prominent obesity doctor explained on a “60 Minutes” episode about the drugs. “Obesity is disease” ...
The Prototype: The Scientist Betting That Worm Secretions Fix Autoimmune Diseases
Plus: The story behind the award-winning science that led to Ozempic, the next astronaut launch and why homework is good for ...